Former Board Member at Kythera Biopharmaceuticals, Inc.
Dr. Schnell is a Managing Director and co-founder of Prospect Venture Partners, a series of dedicated life science venture capital funds with over a $1 billion under management since inception. Dr. Schnell has been actively involved in the formation and growth of numerous successful biomedical and health care companies. He currently serves on the Board of Directors of several private companies, and has served on the boards of Amira Pharmaceuticals (NYSE: BMS acquired), Gloucester Pharmaceuticals (NASDAQ:CELG acquired), Healtheon (NASDAQ: WBMD), Kythera Biopharmaceuticals (NASDAQ: KYTH), Microcide (NASDAQ:MCDE), Neurocrine (NASDAQ:NBIX), Rinat ...
Source: NGM BIOPHARMACEUTICALS INC on 04/17/2014
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like David Schnell M.D.. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: David Schnell M.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.